Sfoglia per AUTORE
MOIA R
Collezione AOU Alessandria

  

Items : 16

Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial. in HemaSphere / Hemasphere. 2026 May 20;10(5):e70393. doi: 10.1002/hem3.70393. eCollection 2026 May.
2026
AOU Alessandria

Galimberti S; Ciavarella S; Marcheselli L; Carella AM; Alesiani F; Rossi FG; Plenteda C; Mannina D; Conconi A; Perrone T; Castellino C; Califano C; Arcari A; Di Raimondo F; Ronconi S; Zanni M; Zilioli VR; Margiotta-Casaluci G; Santoro A; Patti C; Puccini B; Ragaini S; Arcaini L; Andorno A; Lorenzi L; Vegliante MC; Tavarozzi R; Assanto GM; Soscia R; et alii...

Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort. in Blood advances / Blood Adv. 2026 Mar 10;10(5):1687-1699. doi: 10.1182/bloodadvances.2025018757.
2026
AOU Alessandria

Gentile M; Gattei V; Morabito F; Tripepi G; Martino EA; Pitino A; Vigna E; Pasquale R; Ferrarini I; Moia R; Visentin A; Sanna A; Motta M; Moratti M; Sportoletti P; Chiarenza A; Maggi A; Zammit V; Merli M; Innocenti I; Giordano C; Nocilli L; Postorino M; Stelitano C; Ferrario A; Frustaci AM; Riva M; Pepe S; Ibatici A; et alii...

Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy. in Hematological oncology / Hematol Oncol. 2026 Mar;44(2):e70184. doi: 10.1002/hon.70184.
2026
AOU Alessandria

Innocenti I; Sanna A; Angeletti I; Gentile M; Sportoletti P; Scortechini I; Farina L; Giordano A; Quaresmini G; Moia R; Catania G; Mattiello V; Morelli F; Fresa A; Vitale C; Giannarelli D; Visentin A; Autore F; Coscia M; Trentin L; Laurenti L;

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12. in Blood advances / Blood Adv. 2026 Jun 9;10(11):3983-3986. doi: 10.1182/bloodadvances.2025018640.
2026
AOU Alessandria

Krampera M; Farina G; Gentile M; Gaidano G; Gattei V; Abbate PL; Quaranta T; Stirparo L; Tomasso A; Autore F; Tissino E; Zucchetto A; Moia R; Martino EA; Giannarelli D; Catania G; Murru R; Moratti M; Pasquale R; Galitzia A; Ferrarini I; Favrin G; Montalbano MC; Vitale C; Mosca A; Guglielmi F; Laurenti L; Visentin A; Innao V; et alii...

Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53). in British journal of haematology / Br J Haematol. 2026 Jun;208(6):2004-2015. doi: 10.1111/bjh.70535. Epub 2026 May 14.
2026
AOU Alessandria

Bastos-Boente M; Medina-Herrera A; Navarro-Bailón A; Ferrero S; Sarasquete ME; Jiménez C; García-Álvarez M; Antón A; Balanzategui A; Moia R; Re A; Boccomini C; Balzarotti M; Zilioli VR; da Silva MG; Díaz-Gálvez FJ; González-Mena B; Peñarrubia MJ; Fernández-Ferrero S; de Ramón C; Blanco Ó; Cabero A; Ladetto M; García-Sanz R; Gutiérrez NC; Martín García-Sancho A; Alcoceba M;

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial. in Blood advances / Blood Adv. 2026 Jul 24:bloodadvances.2026020780. doi: 10.1182/bloodadvances.2026020780.
2026
AOU Alessandria

Moia R; Almasri M; Carazzolo ME; Cividini L; Tabanelli V; Melle F; Genuardi E; Cosentino C; Maher N; Bellia M; Mahmoud AM; Evangelista A; Quaglia FM; Fiori S; Bomben R; Tisi MC; Riva M; Merli A; Di Rotondo F; Corradini P; Farina L; Castellino C; Castellino A; Zilioli VR; Muzi C; Piazza F; Re A; Hohaus S; Rossi Dardanoni FG; et alii...

2026
AOU Alessandria

Laurenti L; Renzo ND; Coscia M; Angotzi F; Figuera A; Principe MID; Marasca R; Martina VD; Derenzini E; Caracciolo D; Murru R; Conte E; Cantelli M; Pietrantuono G; Morello L; Varettoni M; Vozella F; Malandruccolo L; Scortechini I; Rossi M; Romeo A; Vitale C; Fraticelli V; Galieni P; Innao V; Pocali B; Loseto G; Bulian P; Farina G; et alii...

2026
AOU Alessandria

Mahmoud AM; Rossi D; Merli F; Plenteda C; Galimberti S; Pavone E; Castellino C; Casaroli I; Billio A; Stefani PM; Visco C; Stelitano C; Luppi M; Celli M; Cavallo F; Petrucci L; Di Rocco A; Civita AM; Evangelista A; Zaccaria GM; Bruscaggin A; Almasri M; Talotta D; Genuardi E; Rinaldi A; Cascione L; Ragaini S; Moia R; Gaidano G; et alii...

Molecular Pathogenesis and Targeted Treatment of Richter Transformation. in Biomedicines / Biomedicines. 2026 Feb 2;14(2):347. doi: 10.3390/biomedicines14020347.
2026
AOU Alessandria

Maher N; Karami A; Matti BF; Alwan AF; Sayedi SM; Moia R; Gaidano G; Mouhssine S;

Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study. in The Lancet. Haematology / Lancet Haematol. 2025 Oct;12(10):e777-e788. doi: 10.1016/S2352-3026(25)00252-2. Epub 2025 Sep 17.
2025
AOU Alessandria

Visco C; Tabanelli V; Sacchi MV; Evangelista A; Quaglia FM; Fiori S; Bomben R; Tisi MC; Riva M; Merli A; Rotondo F; Fraenza C; Carazzolo ME; Corradini P; Farina L; Castellino C; Castellino A; Zilioli VR; Muzi C; Piazza F; Re A; Hohaus S; Rossi FG; Musuraca G; Di Rocco A; Puccini B; Sciarra R; Ballerini F; Cavallo F; et alii...

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.
2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Bruno B; Rambaldi A; Laurenti L; Gaidano G; Krampera M; Rivela P; Quaresmini G; Quaglia FM; Moia R; Innocenti I; Frustaci AM; Deodato M; Catania G; Montalbano MC; Boccellato E; Perutelli F; Vitale C; Coscia M;

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Merli F; Arcari A; Zilioli VR; Re A; Volpetti S; Stelitano C; Quaglia FM; Pileri SA; Bruna R; Ferrante M; Sciarra R; Zambello R; Zanni M; Di Rocco A; Ghiggi C; Chini C; Cencini E; Celli M; Puccini B; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C; Moia R; Tisi MC; Visco C;

Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. in British journal of haematology / Br J Haematol. 2022 Mar;196(5):1184-1193. doi: 10.1111/bjh.17971. Epub 2021 Dec 23.
2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Gaidano G; Vitolo U; Pileri SA; Tucci A; Balzarotti M; Ladetto M; Santambrogio E; Righi S; Melle F; Moia R; Motta G; Martelli M; Ciccone G; Di Rocco A; Evangelista A; Nassi L; Novo M; Agostinelli C; Chiappella A; Diop F;

2022
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara
ASL Vercelli

Ghia P; Colia M; Ranghetti P; Perotta E; Capasso A; Varettoni M; Laurenti L; Coscia M; Rivela P; Sancetta R; Motta M; Reda G; Ferrario A; Moia R; Deodato M; Farina L; Schiattone L; Albi E; Scarano E; Heltai S; Scarfò L;

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.
2021
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Vitolo U; Guarini A; Fabbri A; Patti C; Latte G; Spina M; Pascarella A; Vallisa D; Merli F; Di Renzo N; Cabras MG; Moia R; Volpetti S; Tani M; Del Giudice I; Barbero D; Ghislieri M; Drandi D; Genuardi E; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; Kluin-Nelemans HC; Cortelazzo S; Dreyling M; Ladetto M; et alii...

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.
2020
AOU Alessandria
AOU Città della Salute di Torino

Bertoni F; Ladetto M; Cortelazzo S; Piccin A; Grønbæk K; Ferreri A; Santoro A; Molinari A; da Silva MG; Zamò A; Jerkeman M; Paulli M; Novero D; Kolstad A; Barbero D; Schipani M; Mahmoud AM; Ghione P; Favini C; Stefoni V; Diop F; Dahl C; Di Rocco A; Kwee I; Moia R; Evangelista A; Spina V; Eskelund CW; Bruscaggin A; et alii...